Related Experiment Video
Updated: Jun 25, 2026
05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Methods for analysis in pharmacogenomics: lessons from the Pharmacogenetics Research Network Analysis Group
Balaji S Srinivasan1, Jinbo Chen, Cheng Cheng
1Stanford University, CA, USA.
Pharmacogenomics
|February 12, 2009
Summary
The Pharmacogenetics Research Network (PGRN) workshop shared novel pharmacogenomics data analysis methods. These techniques are valuable for genetic association studies, aiding future research and tool development.
Area of Science:
- Genetics
- Bioinformatics
- Pharmacology
Background:
- The Pharmacogenetics Research Network (PGRN) convenes an annual workshop.
- This workshop facilitates the exchange of new methodologies and study designs in pharmacogenomics.
- Discussions focus on real-world data applications within the PGRN membership.
Purpose of the Study:
- To disseminate novel analytical approaches presented at the PGRN workshop.
- To serve as a resource for researchers conducting pharmacogenomics data analysis.
- To guide future development of analytical tools and methods in the field.
Main Methods:
- The report summarizes innovative methods discussed at the PGRN workshop.
- It covers a range of genetic association study techniques.
- Topics include variant identification, haplotype analysis, and multivariate methods.
Main Results:
- Novel approaches for pharmacogenomics data analysis were presented.
- Methods are applicable to various genetic association studies.
- The report highlights techniques for identifying noncoding variants, tag-SNPs, and analyzing gene-gene/gene-environment interactions.
Conclusions:
- The PGRN workshop serves as a platform for advancing pharmacogenomics research.
- The discussed methods have broad applicability beyond pharmacogenomics.
- This report aims to foster further development in genetic data analysis tools.
Related Concept Videos
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...